干扰素-λ2,IFN-λ2
1)IFN-λ2干扰素-λ2
2)Interferon[英][,?nt?'f??r?n][美]['?nt?'f?rɑn]干扰素
1.Preliminary Study on Chintosan/Sodium Alginate as Carriers of Control-released Interferon Microcapsule;干扰素壳聚糖/海藻酸钠微囊控释制剂载体的初步研究
2.Quality Control of Interferon Liposome;干扰素脂质体的质量控制研究
3.Preparation and ciliotoxicity of interferon a-2b nasal spray;α-2b干扰素鼻用喷雾剂的制备及其对黏膜纤毛毒性的研究
英文短句/例句

1.Interferons are species specific.干扰素是物种专一性。
2.New Methods for Purification and Freeze-drying of Recombinant Human Interferon α2b;重组人干扰素α2b的纯化和冻干新方法
3.Studies on the Antiviral Activities and the Immunological Adjuvants of Porcine Interferon-alpha, Interferon-beta & Porcine Interferon-gamma;猪α干扰素、猪β干扰素与猪γ干扰素的抗病毒活性及其免疫佐剂的研究
4.Interferon is scarce and this has been a major obstacle in studying its effects.干扰素的量是很少的,这是研究干扰素作用的主要困难所在。
5.Interferonα, the recombinant human interferonα-1, was developed by Shanghai Institute of Biological Products.干扰素α人α型基因工程干扰素,由上海生物制品研究所研制。
6.Characteristics and Interactions of Recombinant Proteins of Chicken Interferons and Interferon Receptors;鸡干扰素干扰素受体重组蛋白的生物学特性及其相互作用
7.Comparative Experimental Study on Therapy of Schistosomiasis Japonica Hepatic Fibrosis with Interferon-alpha and Gamma in Mice;α干扰素和γ干扰素抗日本血吸虫病肝纤维化实验研究
8.Study of a New Generation of Long-Acting Interferon-Expression, Purification and Activity Assay of Interferon Alpha新一代长效干扰素的研发—干扰素-α的表达纯化及活性测定
9.Clinical observation of interferon on trabeculectom干扰素用于小梁切除术的临床观察
10.Glaucoma filtering surgery with interferon alpha 2b in white rabbits干扰素α-2b与实验性滤过性手术
11.What kind of disease can use the Interferon therapy now?干扰素目前运用于治疗何种疾病?
12.IFN may also be induced by some bacteria, protozoa.某些细菌,原虫都可能诱导干扰素形成。
13.Clinical why to go up to treat chronic second liver with interferon?临床上为什么用干扰素治疗慢性乙肝?
14.Treatment of Hepatitis C with Interferon──A Case Control Study干扰素治疗丙型肝炎──病例对照研究
15.Purification Craft Research of Genetic Engineering IFN α2a;基因工程干扰素α2a纯化工艺研究
16.The Investigation of the Separation and Purification Procedure of Interferon α-2a;干扰素α-2a的分离纯化工艺研究
17.Significant Improvement of Productive Technology of Recombinant Human Interferon- Y;重组人干扰素-γ生产工艺的重大改进
18.Study of IFNα Effect on HL-60 Cells;干扰素对HL-60细胞影响的研究
相关短句/例句

Interferon[英][,?nt?'f??r?n][美]['?nt?'f?rɑn]干扰素
1.Preliminary Study on Chintosan/Sodium Alginate as Carriers of Control-released Interferon Microcapsule;干扰素壳聚糖/海藻酸钠微囊控释制剂载体的初步研究
2.Quality Control of Interferon Liposome;干扰素脂质体的质量控制研究
3.Preparation and ciliotoxicity of interferon a-2b nasal spray;α-2b干扰素鼻用喷雾剂的制备及其对黏膜纤毛毒性的研究
3)Interferon-α干扰素-α
1.Studies on Preparation and Physicochemical Properties of Recombined Human Interferon-α Microspheres;基因重组人干扰素-α微球的制备及理化性质研究
2.Prokaryotic Expression of Cow Interferon-α Fusion Gene;重组奶牛干扰素-α基因的原核表达
3.Curative effect of interferon-α on rat liver fibrosis induced by CCl_4;干扰素-α对CCl_4诱导的大鼠肝纤维化治疗作用
4)pigments interferes色素干扰
5)interferon tau干扰素-tau
1.Optimization of the preparation of interferon tau chitosan-alginate microcapsules;干扰素-tau微囊的制备工艺优化
2.Controlled release of interferon tau from chitosan-alginate microcapsules;壳聚糖-海藻酸钠微囊对干扰素-tau的控释作用
6)interfering factor干扰因素
1.Through the comparison observations under the conditions of opening and drying environments by using the qualitative and quantitative filter paper, we are trying to reveal the environmental and artificial interfering factors to the soluble CO_2 during the observing process in the deep spring water.通过使用定性滤纸和定量滤纸,在开放环境中和干燥器环境中的对比观测实验,试图通过深循环温泉水中溶解CO_2总量的质量分析法,揭示观测过程中的环境干扰因素和人为干扰因素。
2.It is of great importance to study and identify geochemical anomalies caused by some interfering factors and find out the eliminating methods in developing and applying comprehensive oil and gas geochemical exploration techniques so as to recognize the real anomaly information associated with oil and gas activities.初步总结了油气化探中存在的4方面干扰因素:①地表特殊景观的干扰;②土壤性质引起的干扰,包括土壤粘土矿物、化学成分、土壤酸碱度;③地下非油气矿源的干扰,如断层、高碳质及煤层、岩体和地层等的干扰;④其它,如污染河流的影响。
延伸阅读

干扰分子式:CAS号:性质:(一)在分析化学中,一般指试样中的伴生组分对被分析物质(或元素)测量值的影响。这种影响可造成分析结果的系统误差。(二)(1)一个染色丝的第一次交换对由同一个染色丝发生的第二次交换的概率所产生的影响的质量;正(负)干扰表示第一次交换降低(增加)了第二次交换的概率。(2)在病毒学上,指一种病毒在机体中或细胞内,非因免疫抗体的作用而能阻止另一种病毒在同一种机体中或细胞内增殖,引起病变、损害或死亡的现象。(3)仪器等外界因素对测定的影响。